A new model predicts how well maternal vaccines protect babies from Group B Streptococcus, propelling much needed shots through late-stage clinical trials.
Researchers identified existing medications that target novel pathways in E. coli, offering a potential solution to the growing antibiotic resistance threat.
Many species of amoebae naturally bust open biofilms to eat the bacteria inside. Now, scientists are mining these microbial predators for new antibiotics.
By identifying the types of molecules that accumulate inside P. aeruginosa, researchers drew a roadmap for new antibiotic development for combatting these deadly pathogens.
We’ve updated our Privacy Policy to make it clearer how we use your personal data. Please read our Cookie Policy to learn how we use cookies to provide you with a better experience.